Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile
Dana-Farber’s Breast Oncology Center

@dfci_breastonc

Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425

ID: 1491159909794291720

linkhttps://www.dana-farber.org/breast-oncology-program/ calendar_today08-02-2022 21:20:39

4,4K Tweet

5,5K Followers

348 Following

Dana-Farber’s Breast Oncology Center (@dfci_breastonc) 's Twitter Profile Photo
Dana-Farber’s Breast Oncology Center
@dfci_breastonc

6 months ago

New study in Nature Communications👉Exemestane plus everolimus and palbociclib in #MetastaticBreastCancer: Clinical response & genomic/transcriptomic determinants of resistance in a phase I/II trial Ann Partridge MD, MPH Nancy Lin, MD Sara Tolaney Nikhil Wagle, MD (he/him) Nabihah Tayob 👉pubmed.ncbi.nlm.nih.gov/38503755/

New study in <a href="/NatureComms/">Nature Communications</a>👉Exemestane plus everolimus and palbociclib in #MetastaticBreastCancer: Clinical response &amp; genomic/transcriptomic determinants of resistance in a phase I/II trial <a href="/AnnPartridgeMD/">Ann Partridge MD, MPH</a> <a href="/nlinmd/">Nancy Lin, MD</a> <a href="/stolaney1/">Sara Tolaney</a> <a href="/Nikhilwagle/">Nikhil Wagle, MD (he/him)</a> <a href="/NabihahTayob/">Nabihah Tayob</a> 👉pubmed.ncbi.nlm.nih.gov/38503755/